Search

GLP-2 Conjugate Pharmaceutical Composition for Metabolic Bone Diseases, Hanmi Pharm.

The European Patent Office published application EP4082561A1 for Hanmi Pharm. Co., Ltd. on April 15, 2026. The application covers a pharmaceutical composition comprising GLP-2 or a conjugate thereof for preventing or treating metabolic bone diseases, with inventors including CHOI Jae Hyuk, LEE Jin Bong, LEE Sang Hyun, LEE Sang Don, and KIM Min Young. The application spans 31 designated contracting states including major European economies.